X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1806) 1806
Book Review (304) 304
Publication (143) 143
Book Chapter (24) 24
Book / eBook (4) 4
Dissertation (4) 4
Conference Proceeding (3) 3
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1249) 1249
humans (1207) 1207
oncology (568) 568
thyroid neoplasms - pathology (559) 559
cancer (542) 542
female (542) 542
male (488) 488
thyroid cancer (483) 483
middle aged (415) 415
aged (397) 397
anaplastic thyroid carcinoma (395) 395
carcinoma (389) 389
anaplastic thyroid cancer (304) 304
surgery (278) 278
tumors (277) 277
adult (271) 271
cell line, tumor (266) 266
pathology (263) 263
thyroid (255) 255
thyroid neoplasms - genetics (253) 253
anaplastic carcinoma (247) 247
animals (242) 242
expression (230) 230
endocrinology & metabolism (216) 216
chemotherapy (215) 215
immunohistochemistry (207) 207
mutation (207) 207
thyroid neoplasms - metabolism (206) 206
thyroid carcinoma, anaplastic (203) 203
aged, 80 and over (201) 201
prognosis (195) 195
anaplastic lymphoma kinase (194) 194
thyroid carcinoma, anaplastic - pathology (193) 193
carcinoma - pathology (184) 184
thyroid neoplasms - drug therapy (184) 184
care and treatment (174) 174
thyroid neoplasms - therapy (170) 170
mice (167) 167
metastasis (165) 165
apoptosis (155) 155
research (152) 152
radiotherapy (143) 143
survival (139) 139
diagnosis (135) 135
health aspects (133) 133
prognostic-factors (128) 128
genetic aspects (127) 127
analysis (124) 124
abridged index medicus (121) 121
retrospective studies (121) 121
thyroid neoplasms - diagnosis (121) 121
treatment outcome (121) 121
thyroidectomy (117) 117
cell biology (116) 116
therapy (116) 116
thyroid neoplasms - surgery (115) 115
thyroid carcinoma, anaplastic - genetics (111) 111
medicine & public health (109) 109
mutations (109) 109
anaplastic (106) 106
antineoplastic agents - therapeutic use (106) 106
gene expression (106) 106
thyroid carcinoma (105) 105
thyroid gland (104) 104
papillary (102) 102
cancer therapies (98) 98
receptor protein-tyrosine kinases - genetics (97) 97
thyroid diseases (97) 97
apoptosis - drug effects (94) 94
combined modality therapy (94) 94
proteins (93) 93
carcinoma - genetics (92) 92
thyroid neoplasms - mortality (92) 92
gene expression regulation, neoplastic (90) 90
kinases (90) 90
lung cancer (89) 89
neoplasm staging (89) 89
thyroid carcinoma, anaplastic - drug therapy (89) 89
mice, nude (88) 88
development and progression (86) 86
antineoplastic agents - pharmacology (84) 84
gene (84) 84
thyroid carcinoma, anaplastic - metabolism (82) 82
lymphomas (81) 81
article (79) 79
proto-oncogene proteins b-raf - genetics (77) 77
braf (74) 74
carcinoma, papillary - pathology (74) 74
cell proliferation - drug effects (74) 74
patients (72) 72
thyroid neoplasms - radiotherapy (71) 71
growth (70) 70
medical prognosis (70) 70
cell proliferation (69) 69
papillary thyroid carcinoma (69) 69
carcinoma, papillary (68) 68
doxorubicin (68) 68
gland (68) 68
lung neoplasms - genetics (68) 68
management (68) 68
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1711) 1711
Japanese (33) 33
Korean (22) 22
French (21) 21
German (18) 18
Spanish (9) 9
Italian (6) 6
Chinese (5) 5
Portuguese (4) 4
Croatian (3) 3
Russian (2) 2
Czech (1) 1
Dutch (1) 1
Latvian (1) 1
Polish (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 11/2010, Volume 8, Issue 11, pp. 1228 - 1274
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 09/2015, Volume 13, Issue 9, pp. 1140 - 1150
Journal Article
Journal Article
Thyroid : official journal of the American Thyroid Association, ISSN 1050-7256, 09/2017, Volume 27, Issue 9, pp. 1142 - 1148
Background: Therapeutic options for treating advanced or metastatic medullary thyroid carcinoma (MTC) and anaplastic thyroid carcinoma (ATC) are still limited... 
anaplastic thyroid carcinoma | overall survival | Phase II clinical trial | sorafenib | medullary thyroid carcinoma | progression-free survival | EFFICACY | PHASE-II | CANCER | TRIAL | INHIBITION | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | Niacinamide - analogs & derivatives | Humans | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Hand-Foot Syndrome - etiology | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Thyroid Carcinoma, Anaplastic - ethnology | Neoplasm Grading | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Diarrhea - ethnology | Adult | Female | Carcinoma, Neuroendocrine - ethnology | Thyroid Gland - drug effects | Thyroid Carcinoma, Anaplastic - drug therapy | Carcinoma, Neuroendocrine - drug therapy | Japan | Alopecia - ethnology | Niacinamide - adverse effects | Thyroid Neoplasms - ethnology | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Carcinoma, Neuroendocrine - secondary | Hand-Foot Syndrome - ethnology | Thyroid Neoplasms - drug therapy | Tumor Burden - drug effects | Carcinoma, Neuroendocrine - pathology | Protein Kinase Inhibitors - therapeutic use | Thyroid Gland - pathology | Hypertension - ethnology | Survival Analysis | Thyroid Carcinoma, Anaplastic - pathology | Thyroid Neoplasms - secondary | Alopecia - chemically induced | Patient Dropouts - ethnology | Thyroid Neoplasms - pathology | Index Medicus | Thyroid Cancer and Nodules
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 08/2012, Volume 97, Issue 8, pp. 2566 - 2572
Journal Article
Human Pathology, ISSN 0046-8177, 2017, Volume 65, pp. 133 - 139
Summary Metastatic papillary thyroid carcinoma without an identifiable primary tumor despite extensive microscopic examination of the thyroid gland is a rare... 
Pathology | Lymph node metastasis | Occult primary thyroid carcinoma | Poorly differentiated thyroid carcinoma | BRAF | Papillary thyroid carcinoma | Anaplastic thyroid carcinoma | METAANALYSIS | MICROCARCINOMA | PATHOLOGY | SPONTANEOUS REGRESSION | FEATURES | MELANOMA | FOLLICULAR VARIANT | MUTATIONS | SPECTRUM | PROGRESSION | Immunohistochemistry | Humans | Middle Aged | Male | Thyroid Neoplasms - therapy | Neoplasm Grading | DNA Mutational Analysis | Adult | Female | Thyroid Carcinoma, Anaplastic - therapy | Cell Differentiation | Retrospective Studies | Carcinoma - secondary | Genetic Predisposition to Disease | Neoplasms, Unknown Primary - genetics | Thyroid Carcinoma, Anaplastic - secondary | Thyroid Carcinoma, Anaplastic - genetics | Lymphatic Metastasis | Thyroid Cancer, Papillary | Thyroid Neoplasms - genetics | Phenotype | Carcinoma, Papillary | Proto-Oncogene Proteins B-raf - genetics | Neoplasms, Unknown Primary - therapy | Carcinoma - genetics | Carcinoma - therapy | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasms, Unknown Primary - pathology | Thyroid Neoplasms - pathology | Thyroid gland | Carcinoma | Metastasis | Thyroid diseases | Cancer | Lymphatic system | Thyroid cancer | Medical prognosis | Melanoma | Patients | Iodine | Tumors | Index Medicus | occult primary thyroid carcinoma | lymph node metastasis
Journal Article
Diagnostic Cytopathology, ISSN 8755-1039, 01/2016, Volume 44, Issue 1, pp. 26 - 31
Journal Article
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 8, pp. e103871 - e103871
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 04/2014, Volume 111, Issue 16, pp. E1600 - E1609
Anaplastic thyroid carcinoma (ATC) has among the worst prognoses of any solid malignancy. The low incidence of the disease has in part precluded systematic... 
Vemurafenib | Anaplastic thyroid cancer | Genetically-engineered mouse model | Mek inhibitor | PHOSPHATIDYLINOSITOL 3-KINASE/AKT | MULTIDISCIPLINARY SCIENCES | vemurafenib | MEK inhibitor | TUMORS | BRAF(V600E) | genetically-engineered mouse model | INHIBITION | GENE | PATHWAY | anaplastic thyroid cancer | MUTATIONS | EXPRESSION | ASSOCIATION | TRANSGENIC MICE | Humans | Thyroid Carcinoma, Anaplastic | Thyroid Neoplasms - blood | Cell Differentiation - genetics | MAP Kinase Signaling System - genetics | Neoplasm Grading | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma - pathology | Thyroid Gland - drug effects | Disease Models, Animal | Thyrotropin - blood | Carcinoma - drug therapy | Carcinoma - blood | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Tumor Suppressor Protein p53 - metabolism | Mice, Transgenic | Mutation - genetics | Disease Progression | Thyroid Cancer, Papillary | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Homozygote | Thyroid Neoplasms - genetics | Animals | MAP Kinase Signaling System - drug effects | Thyroid Neoplasms - drug therapy | Carcinoma, Papillary | Cell Differentiation - drug effects | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Thyroid Gland - pathology | Carcinoma - genetics | Cell Proliferation - drug effects | Mice | Thyroid Neoplasms - pathology | Survival analysis | Signal transduction | Thyroid cancer | Rodents | Oncology | Mutation | Kinases | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 02/2015, Volume 39, Issue 2, pp. 260 - 265
Papillary thyroid carcinoma is the most common thyroid carcinoma and has a generally favorable prognosis. There are several well-characterized variants, some... 
hobnail anaplastic thyroid carcinoma | poorly differentiated thyroid carcinoma | papillary thyroid carcinoma | micropapillary | anaplastic thyroid carcinoma | SURGERY |